Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Renal Cell Carcinoma, Clear Cell Adenocarcinoma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Temporarily pausedNCT00033956
What this trial is testing

Evaluation of M40403 for the Prevention of Dose Limiting Toxicities of High Dose IL-2

Who this might be right for
IL-2 Induced Hypotension
MetaPhore Pharmaceuticals 48
Not applicableStudy completedNCT00717743
What this trial is testing

T Regulatory Cells in Renal Cell Carcinoma (PILOT STUDY)

Who this might be right for
Renal Cell Carcinoma
National University Hospital, Singapore
Early research (Phase 1)Ended earlyNCT03343613
What this trial is testing

LY3381916 Alone or in Combination With LY3300054 in Participants With Solid Tumors

Who this might be right for
Solid TumorNon Small Cell Lung CancerRenal Cell Carcinoma+1 more
Eli Lilly and Company 60
Testing effectiveness (Phase 2)Study completedNCT00618982
What this trial is testing

Sorafenib Dose Escalation in Renal Cell Carcinoma

Who this might be right for
Carcinoma, Renal Cell
Bayer 83
Early research (Phase 1)Ended earlyNCT05769959
What this trial is testing

Study of RO7515629 in Participants With HLA-G Positive Solid Tumors

Who this might be right for
Renal Cell CarcinomaNon-small Cell Lung CancerPancreatic Adenocarcinoma+2 more
Hoffmann-La Roche 3
Large-scale testing (Phase 3)Not Yet RecruitingNCT07165418
What this trial is testing

A Comparison of Vorolanib Tablets Combined With Everolimus Versus Sunitinib in Patients With Advanced Renal Cell Carcinoma Who Have Progressed After Treatment With Immunotherapy Monotherapy or in Combination With TKI

Who this might be right for
Renal Cell Carcinoma (RCC)
Peking University Cancer Hospital & Institute 116
Not applicableLooking for participantsNCT07714018
What this trial is testing

Comparing Two Weight Loss Programs for the Prevention of Kidney Cancer Progression Among Patients With Small Renal Masses on Active Surveillance

Who this might be right for
Renal Cell Carcinoma (RCC)
Roswell Park Cancer Institute 20
Not applicableStudy completedNCT03176485
What this trial is testing

Evaluation of Pathway Modulation by Raf, MEK, & Kinase Inhibitors

Who this might be right for
Metastatic CancerMelanomaColon Cancer+6 more
University of Arizona 45
Large-scale testing (Phase 3)Study completedNCT01265810
What this trial is testing

Caphosol in Oral Mucositis Due to Targeted Therapy

Who this might be right for
Oral ComplaintsRenal Cell CarcinomaHepatocellular Carcinoma+1 more
Impaqtt Foundation 64
Not applicableUnknownNCT00295997
What this trial is testing

Donor Stem Cell Transplant in Treating Patients With Hematologic Cancer, Metastatic Kidney Cancer, or Aplastic Anemia

Who this might be right for
Chronic Myeloproliferative DisordersKidney CancerLeukemia+4 more
University of California, San Francisco 35
Testing effectiveness (Phase 2)WithdrawnNCT00489710
What this trial is testing

Talabostat in Treating Patients With Metastatic Kidney Cancer

Who this might be right for
Kidney Cancer
University of Nebraska
Testing effectiveness (Phase 2)WithdrawnNCT02962804
What this trial is testing

Combination Radiation and PD-1 Inhibition in Metastatic or Recurrent Renal Cell Carcinoma (RCC)

Who this might be right for
Carcinoma, Renal Cell
University of Kansas Medical Center
Testing effectiveness (Phase 2)Ended earlyNCT05935748
What this trial is testing

Ph2 Study NKT2152 With Palbociclib & Sasanlimab in Subjects With Advanced Clear Cell Renal Cell Carcinoma (ccRcc)

Who this might be right for
ccRCCClear Cell Renal Cell CarcinomaKidney Cancer+18 more
NiKang Therapeutics, Inc. 18
Testing effectiveness (Phase 2)UnknownNCT00003181
What this trial is testing

Interleukin-2, Vinblastine, and GM-CSF in Treating Patients With Metastatic Kidney Cancer

Who this might be right for
Kidney Cancer
Hope Cancer Institute, Inc. 35
Testing effectiveness (Phase 2)Study completedNCT02992912
What this trial is testing

Atezolizumab With Stereotactic Ablative Radiotherapy in Patients With Metastatic Tumours

Who this might be right for
Patients With Metastatic Tumours (Colorectal Cancer, Non-small Lung Cancer, Renal Cell Carcinoma or Sarcoma )
Gustave Roussy, Cancer Campus, Grand Paris 138
Not applicableStudy completedNCT00610012
What this trial is testing

Tumor Registry of Advanced Renal Cell Carcinoma

Who this might be right for
Renal Cell Carcinoma
iOMEDICO AG 1,500
Not applicableEnded earlyNCT01033981
What this trial is testing

Cost Effectiveness Of Sunitinib In Central America And Caribbean

Who this might be right for
Metastatic Renal Cell Carcinoma
Pfizer 4
Testing effectiveness (Phase 2)Ended earlyNCT03393936
What this trial is testing

Safety and Efficacy of CCT301 CAR-T in Adult Subjects With Recurrent or Refractory Stage IV Renal Cell Carcinoma

Who this might be right for
Renal Cell Carcinoma
Shanghai PerHum Therapeutics Co., Ltd. 66
Not applicableLooking for participantsNCT06035211
What this trial is testing

Effect on Pre-operative Anxiety of a Personalized Three-dimensional Kidney Model Prior to Nephron-sparing Surgery- Rein 3D Anxiety

Who this might be right for
Tumoral Kidney
University Hospital, Bordeaux 192
Early research (Phase 1)Study completedNCT01015911
What this trial is testing

Dose-escalation Trial of SGN-75 in CD70-positive Non-Hodgkin Lymphoma or Renal Cell Carcinoma

Who this might be right for
Carcinoma, Renal CellLymphoma, Non-Hodgkin
Seagen Inc. 58
Next Page